Broadly Epi https://validator.w3.org/feed/docs/rss2.html Epi Explained: Understanding Herd Immunity Epi Explained: Understanding Age Adjustment Epi Explained: Understanding Health Indicators Epi Explained: Understanding Risk Factors CPH Focus: Evidence-Based Approaches to Public Health: Epidemiology – Methods to Reduce Bias CPH Focus: Communication : Message Development and Dissemination Community Protection Guide: Chemical Agents & Community Response CPH Focus: Evidence-Based Approaches to Public Health: Epidemiology – Confounding Variables and Effect Modification CPH Focus: Communication : Audience analysis and segmentation CPH Focus: Communication : Cultural Influences on Health Behaviors CPH Focus: Evidence-Based Approaches to Public Health : Regression Analysis : Logistic Regression CPH Focus: Strategies for Culturally Competent Communication CPH Focus: Evidence-Based Approaches to Public Health : Regression Analysis : Survival Analysis CPH Focus: Communication : Principles of Social Marketing CPH Focus: Evidence-Based Approaches to Public Health : Regression Analysis : Linear Regression CPH Focus: Evidence-Based Approaches to Public Health : Hypothesis Testing : Parametric and Non-parametric Tests CPH Focus: Evidence-Based Approaches to Public Health : Hypothesis Testing : Null and Alternative Hypotheses CPH Focus: Evidence-Based Approaches to Public Health: Epidemiology – Hill’s Criteria for Causation CPH Focus: Evidence-Based Approaches to Public Health: Epidemiology – Types of Bias Contact Us Broadly Epi – Epidemiology, Broadly Speaking. CPH Focus: Evidence-Based Approaches to Public Health : Hypothesis Testing : Type I and Type II errors CPH Focus: Evidence-Based Approaches to Public Health: Biostatistics – Probability: Probability Distributions CPH Focus: Evidence-Based Approaches to Public Health: Biostatistics – Probability: Basic Probability Concepts LGBTQIA+ Health Resources MMWR Booster for: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 / March 4, 2022 / 71(9);352–358 MMWR Booster for: Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021 / September 3, 2021 / 70(35);1195–1200 Home MMWR Booster for: Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States, 2017–2019 / September 3, 2021 / 70(35);1191–1194 MMWR Booster for: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 / March 4, 2022 / 71(9);347–351 CPH Focus: Evidence-Based Approaches to Public Health: Biostatistics – Inferential Statistics: Confidence Intervals CPH Focus: Evidence-Based Approaches to Public Health: Biostatistics – Inferential Statistics: p-Values and Statistical Significance List of Resources for People Who Use Drugs Protected: SILAS – The Smart Interactive Library and Archival System Community Experts Issue 3: Rowan Odom’s Story – Living with an Undiagnosed Chronic Illness Social Vulnerability Index Archive and Data Mart Data Rebellion MMWR Booster for: Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 / February 25, 2022 / 71(8);285–289 Broadly Epi MMWR Archive Database MMWR Booster for: Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020 / September 3, 2021 / 70(35);1201–1205 MMWR Booster for: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 / September 3, 2021 / 70(35);1183–1190 MMWR Booster for: Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021 / February 25, 2022 / 71(8);290–292 MMWR Booster for: Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021 / March 4, 2022 / 71(9);361–362 MMWR Booster for: SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 / March 4, 2022 / 71(9);341–346 MMWR Booster for: Notes from the Field: Tuberculosis Outbreak Linked to a Contaminated Bone Graft Product Used in Spinal Surgery — Delaware, March–June 2021 / September 10, 2021 / 70(36);1261–1263 MMWR Booster for: Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021 / February 25, 2022 / 71(8);299–305 MMWR Booster for: Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021 / September 10, 2021 / 70(36);1255–1260 MMWR Booster for: Notes from the Field: First Reports of Locally Transmitted Seoul Hantavirus Infection — District of Columbia, May 2018–December 2018 / March 4, 2022 / 71(9);359–360 MMWR Booster for: Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021 / September 10, 2021 / 70(36);1249–1254 Blog